Trademark: 87936981
Status Date
Monday, December 5, 2022
Filing Date
Friday, May 25, 2018
Published for Opposition
Tuesday, December 25, 2018
Abandoned Date
Monday, December 5, 2022
5 A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and instruments, and surgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations
10 Medical devices, namely, lasers and fibre-optic wires and cables for use in photodynamic therapy with the administration of a photosensitizing agent for the treatment of cancer
Dec 5, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 5, 2022
Abandonment - No Use Statement Filed
May 4, 2022
Notice Of Approval Of Extension Request E-Mailed
May 3, 2022
Sou Extension 5 Granted
Apr 27, 2022
Sou Extension 5 Filed
May 3, 2022
Case Assigned To Intent To Use Paralegal
Apr 27, 2022
Sou Teas Extension Received
Oct 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 14, 2021
Sou Extension 4 Granted
Oct 14, 2021
Sou Extension 4 Filed
Oct 14, 2021
Sou Teas Extension Received
Apr 24, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 22, 2021
Sou Extension 3 Granted
Apr 22, 2021
Sou Extension 3 Filed
Apr 22, 2021
Sou Teas Extension Received
Oct 29, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 27, 2020
Sou Extension 2 Granted
Oct 27, 2020
Sou Extension 2 Filed
Oct 27, 2020
Sou Teas Extension Received
Apr 22, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 20, 2020
Sou Extension 1 Granted
Apr 20, 2020
Sou Extension 1 Filed
Apr 20, 2020
Sou Teas Extension Received
Apr 7, 2020
Data Modification Completed
Oct 29, 2019
Noa E-Mailed - Sou Required From Applicant
Sep 18, 2019
Ttab Release Case To Trademarks
Sep 18, 2019
Opposition Terminated No. 999999
Sep 18, 2019
Opposition Dismissed No. 999999
Jun 21, 2019
Opposition Instituted No. 999999
Feb 6, 2019
Assignment Of Ownership Not Updated Automatically
Jan 31, 2019
Changes/Corrections After Pub Approval Entered
Jan 30, 2019
Assigned To Petition Staff
Jan 24, 2019
Extension Of Time To Oppose Received
Jan 22, 2019
Teas Post Publication Amendment Received
Dec 25, 2018
Official Gazette Publication Confirmation E-Mailed
Dec 25, 2018
Published For Opposition
Dec 5, 2018
Notification Of Notice Of Publication E-Mailed
Nov 16, 2018
Assigned To Lie
Oct 31, 2018
Approved For Pub - Principal Register
Oct 31, 2018
Examiner's Amendment Entered
Oct 31, 2018
Notification Of Examiners Amendment E-Mailed
Oct 31, 2018
Examiners Amendment E-Mailed
Oct 31, 2018
Examiners Amendment -Written
Oct 26, 2018
Previous Allowance Count Withdrawn
Oct 2, 2018
Withdrawn From Pub - Og Review Query
Sep 15, 2018
Approved For Pub - Principal Register
Sep 15, 2018
Assigned To Examiner
Jun 3, 2018
New Application Office Supplied Data Entered
May 29, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
